High performance inkjet printed embedded electrochemical sensors for monitoring hypoxia in a gut bilayer microfluidic chip. Issue 9 (4th March 2022)

• Record Type: Journal Article
• Authors: Khalid, Muhammad Asad Ullah; Kim, Kyung Hwan; Chethikkattuveli Salih, Abdul Rahim; Hyun, Kinam; Park, Sung Hyuk; Kang, Bohye; Soomro, Afaque Manzoor; Ali, Muhsin; Jun, Yesl; Huh, Dongeun; Cho, Heeyeong; Choi, Kyung Hyun
• Is Part Of: Lab on a chip. Volume 22:Issue 9(2022)
• Page Start: 1764
• Page End: 1778
• Publication Date: 2022-03-04
• Subjects: Miniature electronic equipment -- Periodicals; Combinatorial chemistry -- Periodicals; Biotechnology -- Periodicals; 543.0813
• DOI: 10.1039/d1lc01079d
• Languages: English
• ISSNs: 1473-0197

Abstract

Abstract : High performance embedded electrochemical sensors fabricated with an inkjet printing system in a gut bilayer microfluidic chip monitored developmental and induced hypoxia. Abstract : Sensing devices have shown tremendous potential for monitoring state-of-the-art organ chip devices. However, challenges like miniaturization while maintaining higher performance, longer operating times for continuous monitoring, and fabrication complexities limit their use. Herein simple, low-cost, and solution-processible inkjet dispenser printing of embedded electrochemical sensors for dissolved oxygen (DO) and reactive oxygen species (ROS) is proposed for monitoring developmental (initially normoxia) and induced hypoxia in a custom-developed gut bilayer microfluidic chip platform for 6 days. The DO sensors showed a high sensitivity of 31.1 nA L mg −1 with a limit of detection (LOD) of 0.67 mg L −1 within the 0–9 mg L −1 range, whereas the ROS sensor had a higher sensitivity of 1.44 nA μm −1 with a limit of detection of 1.7 μm within the 0–300 μm range. The dynamics of the barrier tight junctions are quantified with the help of an in-house developed trans -epithelial–endothelial electrical impedance (TEEI) sensor. Immunofluorescence staining was used to evaluate the expressions of HIF-1α and tight junction protein (TJP) ZO-1. This platform can also be used to enhance bioavailability assays, drug transport studies under an oxygen-controlled environment, and even other barrier organ models, as well as for various applications like toxicity testing, disease modeling and drug screening.